InterAx Biotech gibt den Erhalt einer äußerst wettbewerbsorientierten europäischen Förderung zur Finanzierung seiner Arzneimittelentwicklung bekannt und informiert über wichtige Finanzdaten

Contributed by: ACCESS Newswire

Logo

Tags

Biotechnology

InterAx Biotech AG

Financing

More Like This

InterAx and Alveus Announce Strategic Research and Licensing Agreement to Develop Differentiated Therapeutic Candidate for Metabolic Disease

Champions Oncology erhält für seinen europäischen Forschungsstandort eine ISO-9001:2015-Akkreditierung und ATS-Zertifizierung

BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development

BerGenBio First Quarter Results 2024: Advancing to the Next Stage of Development

PR Newswire associated0

ACROBiosystems Innovation Day Lands in Zurich: Top Minds Unite to Explore Biotech Frontiers

BioArctic: Interim Report for the period April - June 2025

PR Newswire associated0

Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

PR Newswire associated0

BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.